Sign in

CIK 0001006281 · Non-accelerated filer<br>Smaller reporting company

Protalix BioTherapeutics, Inc.

Sign in to watch
Ticker
PLX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
650643773
Phone
201-696-9345
Business address
2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, NJ, 07601
Former names
ORTHODONTIX INC, EMBASSY ACQUISITION CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy President & CEO bought 50,000 shares at $0.81 ($40,500)
  8. 4 Open-market sale 10% owner sold 2,500,000 shares at $0.32 ($792,000)
  9. 4 Option exercise Executive VP, R&D acquired 122,162 shares (option exercise)
  10. 4 Open-market buy Vice President & CFO bought 10,000 shares at $0.78 ($7,800)
  11. 4 Open-market buy 10% owner bought 4,000,423 shares at an average $1.00 ($4,000,436)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Other disposition Director disposed of 1,509,948 shares (other)

Page 5 of 12 · 223 filings